ArticleMetabolites2025

Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study.

Xuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.